Led by diagnostics industry veteran Mara G. Aspinall, Health Catalysts Group is an Arizona based consulting and informatics firm focused on the success of life sciences companies.
Tucson, Arizona. April 20, 2020 – Health Catalysts Group announces the release of its Diagnostics Year in Review Report, an annual collection of data recapping the most important trends in the Mergers & Acquisitions, IPOs, stock market changes, product availability and regulation relating to the Diagnostic Industry.
“Diagnostics have never been more important or visible on the world stage as they are today in the midst of our COVID-19 global pandemic. Diagnostic researchers, developers, and manufacturers are working to help make testing targeted and broadly available to help manage
the end this pandemic,” says Mara G. Aspinall, Managing Director of Health Catalysts Group. “This is the critical moment to build awareness worldwide of the importance of an accurate and timely diagnostic test.”
The Health Catalysts Diagnostics Year in Review will help to educate the healthcare industry
about diagnostics products and business models.
Health Catalysts Group is an Arizona based consulting and informatics firm focused on the success of life sciences companies.
About Health Catalysts Group:
Health Catalysts Group is a consulting and informatics firm focused on the success of life sciences companies. Health Catalysts helps companies leverage their data and technology to accelerate growth and gain unique market position. Health Catalysts also helps build young companies through venture investment.
For more information or to request a copy of The Diagnostics Year in Review, please contact:
Health Catalysts Group